{"id":3466,"date":"2026-05-23T15:25:32","date_gmt":"2026-05-23T09:55:32","guid":{"rendered":"https:\/\/kanpurlive.in\/hn\/%e0%a4%ad%e0%a4%be%e0%a4%b0%e0%a4%a4-%e0%a4%95%e0%a5%80-%e0%a4%85%e0%a4%97%e0%a5%8d%e0%a4%b0%e0%a4%a3%e0%a5%80-car-t-%e0%a4%b8%e0%a5%87%e0%a4%b2-%e0%a4%a5%e0%a5%87%e0%a4%b0%e0%a5%87%e0%a4%aa%e0%a5%80\/"},"modified":"2026-05-23T18:57:25","modified_gmt":"2026-05-23T13:27:25","slug":"indias-leading-car-t-cell-therapy-provides-relief-to-blood-cancer-patients-for-two-years","status":"publish","type":"post","link":"https:\/\/kanpurlive.in\/hn\/indias-leading-car-t-cell-therapy-provides-relief-to-blood-cancer-patients-for-two-years\/","title":{"rendered":"\u092d\u093e\u0930\u0924 \u0915\u0940 \u0905\u0917\u094d\u0930\u0923\u0940 CAR T-\u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0938\u0947 \u092c\u094d\u0932\u0921 \u0915\u0948\u0902\u0938\u0930 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u094b \u0926\u094b \u0938\u093e\u0932 \u0924\u0915 \u0930\u093e\u0939\u0924"},"content":{"rendered":"
\n
<\/div>\n

\u092c\u0947\u0902\u0917\u0932\u0941\u0930\u0941 (\u0915\u0930\u094d\u0928\u093e\u091f\u0915) [\u092d\u093e\u0930\u0924], 21 \u092e\u0908:<\/strong> \u092d\u093e\u0930\u0924\u0940\u092f \u0911\u0928\u094d\u0915\u094b\u0932\u0949\u091c\u0940 \u0926\u0947\u0916\u092d\u093e\u0932 \u092e\u0947\u0902 \u090f\u0915 \u092e\u0939\u0924\u094d\u0935\u092a\u0942\u0930\u094d\u0923 \u0909\u092a\u0932\u092c\u094d\u0927\u093f \u0915\u0947 \u0930\u0942\u092a \u092e\u0947\u0902, \u0915\u0940 \u092e\u0947\u0921-\u0907\u0928-\u0907\u0902\u0921\u093f\u092f\u093e CAR T-\u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0928\u0947 \u0906\u0915\u094d\u0930\u093e\u092e\u0915 \u092c\u094d\u0932\u0921 \u0915\u0948\u0902\u0938\u0930 \u0938\u0947 \u092a\u0940\u0921\u093c\u093f\u0924 \u092e\u0930\u0940\u091c\u094b\u0902 \u092e\u0947\u0902 \u0926\u0947\u0936 \u0915\u0940 \u092a\u0939\u0932\u0940 \u091c\u094d\u091e\u093e\u0924 \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u093f\u0915 \u0930\u094b\u0917\u092e\u0941\u0915\u094d\u0924\u093f \u0939\u093e\u0938\u093f\u0932 \u0915\u0940 \u0939\u0948\u0964 \u0935\u0930\u094d\u0937 2022 \u092e\u0947\u0902 \u0909\u092a\u091a\u093e\u0930 \u092a\u094d\u0930\u093e\u092a\u094d\u0924 \u0915\u0930\u0928\u0947 \u0935\u093e\u0932\u0947 \u0938\u093e\u0924 \u092e\u0930\u0940\u091c \u0905\u092c \u0926\u094b \u0935\u0930\u094d\u0937\u094b\u0902 \u0938\u0947 \u0905\u0927\u093f\u0915 \u092a\u094d\u0930\u094b\u0917\u094d\u0930\u0947\u0936\u0928-\u092b\u094d\u0930\u0940 \u0938\u0930\u094d\u0935\u093e\u0907\u0935\u0932 (PFS) \u092a\u093e\u0930 \u0915\u0930 \u091a\u0941\u0915\u0947 \u0939\u0948\u0902, \u091c\u094b \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0935\u093f\u0915\u0938\u093f\u0924 \u0915\u093f\u0938\u0940 \u092d\u0940 CAR T-\u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0947 \u0932\u093f\u090f \u092a\u0939\u0932\u0940 \u0909\u092a\u0932\u092c\u094d\u0927\u093f \u0939\u0948\u0964 \u092f\u0939 \u0938\u092b\u0932\u0924\u093e Immuneel \u0915\u0947 \u0926\u0943\u0937\u094d\u091f\u093f\u0915\u094b\u0923 \u0915\u0940 \u0938\u094d\u0925\u093e\u092f\u093f\u0924\u094d\u0935 \u0915\u094d\u0937\u092e\u0924\u093e \u0914\u0930 \u0906\u0915\u094d\u0930\u093e\u092e\u0915 \u092c\u094d\u0932\u0921 \u0915\u0948\u0902\u0938\u0930 \u0915\u0947 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u0947 \u0909\u092a\u091a\u093e\u0930 \u092a\u0930\u093f\u0923\u093e\u092e\u094b\u0902 \u0915\u094b \u092c\u0926\u0932\u0928\u0947 \u0915\u0940 \u0909\u0938\u0915\u0940 \u0915\u094d\u0937\u092e\u0924\u093e \u0915\u094b \u092e\u091c\u092c\u0942\u0924 \u0915\u0930\u0924\u0940 \u0939\u0948\u0964<\/p>\n

\u092f\u0939 CAR T-\u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940, \u091c\u093f\u0938\u0947 Varnimcabtagene autoleucel (IMN-003A) \u0915\u0947 \u0928\u093e\u092e \u0938\u0947 \u091c\u093e\u0928\u093e \u091c\u093e\u0924\u093e \u0939\u0948, Immuneel \u0915\u0947 IMAGINE \u092b\u0947\u091c-2 \u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u091f\u094d\u0930\u093e\u092f\u0932 \u0915\u0947 \u0905\u0902\u0924\u0930\u094d\u0917\u0924 \u0935\u093f\u0915\u0938\u093f\u0924 \u0915\u0940 \u0917\u0908 \u0939\u0948\u0964 \u0907\u0938\u0915\u093e \u0909\u0926\u094d\u0926\u0947\u0936\u094d\u092f relapsed \u092f\u093e refractory CD19-positive B-cell Non-Hodgkin Lymphoma (B-NHL) \u0938\u0947 \u092a\u0940\u0921\u093c\u093f\u0924 \u0935\u092f\u0938\u094d\u0915 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u093e \u0909\u092a\u091a\u093e\u0930 \u0915\u0930\u0928\u093e \u0939\u0948, \u091c\u094b \u092c\u094d\u0932\u0921 \u0915\u0948\u0902\u0938\u0930 \u0915\u0947 \u0938\u092c\u0938\u0947 \u0906\u0915\u094d\u0930\u093e\u092e\u0915 \u092a\u094d\u0930\u0915\u093e\u0930\u094b\u0902 \u092e\u0947\u0902 \u0938\u0947 \u090f\u0915 \u092e\u093e\u0928\u093e \u091c\u093e\u0924\u093e \u0939\u0948 \u0914\u0930 \u091c\u093f\u0938\u092e\u0947\u0902 \u0915\u0908 \u092e\u0930\u0940\u091c \u092a\u093e\u0930\u0902\u092a\u0930\u093f\u0915 \u0909\u092a\u091a\u093e\u0930\u094b\u0902 \u0915\u093e \u091c\u0935\u093e\u092c \u0928\u0939\u0940\u0902 \u0926\u0947\u0924\u0947\u0964 \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0905\u092c \u0924\u0915 CAR T-\u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u091c\u0948\u0938\u0947 \u0905\u0917\u0932\u0940 \u092a\u0940\u0922\u093c\u0940 \u0915\u0947 \u0909\u092a\u091a\u093e\u0930 \u0932\u093e\u0917\u0924 \u0914\u0930 \u0907\u0902\u092b\u094d\u0930\u093e\u0938\u094d\u091f\u094d\u0930\u0915\u094d\u091a\u0930 \u0915\u0940 \u0938\u0940\u092e\u093e\u0913\u0902 \u0915\u0947 \u0915\u093e\u0930\u0923 \u0938\u0940\u092e\u093f\u0924 \u0925\u0947\u0964<\/p>\n

\u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0947 \u0909\u0924\u094d\u0938\u093e\u0939\u091c\u0928\u0915 \u092a\u0930\u093f\u0923\u093e\u092e\u094b\u0902 \u092e\u0947\u0902 Day 90 \u092a\u0930 83% Overall Response Rate (ORR) \u0914\u0930 Day 365 \u092a\u0930 50% ORR \u0926\u0930\u094d\u091c \u0915\u093f\u092f\u093e \u0917\u092f\u093e, \u091c\u092c\u0915\u093f Complete Response Rate 83% \u0930\u0939\u0940\u0964 \u092f\u0939 \u092a\u0930\u093f\u0923\u093e\u092e \u092d\u093e\u0930\u0924\u0940\u092f CAR T-\u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0947 \u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u092e\u093e\u0928\u0915\u094b\u0902 \u092e\u0947\u0902 \u0905\u092c \u0924\u0915 \u0915\u0947 \u0938\u0930\u094d\u0935\u094b\u091a\u094d\u091a \u092a\u0930\u093f\u0923\u093e\u092e\u094b\u0902 \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 \u0939\u0948\u0902\u0964 \u0905\u092c \u0924\u0915 \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 100 \u0938\u0947 \u0905\u0927\u093f\u0915 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u094b \u092f\u0939 \u0925\u0947\u0930\u0947\u092a\u0940 \u0926\u0940 \u091c\u093e \u091a\u0941\u0915\u0940 \u0939\u0948, \u091c\u094b \u091c\u091f\u093f\u0932 \u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u094b \u0932\u0917\u093e\u0924\u093e\u0930 \u0938\u092b\u0932 \u092a\u0930\u093f\u0923\u093e\u092e\u094b\u0902 \u0914\u0930 \u0905\u0928\u0941\u0915\u0942\u0932 \u0938\u0941\u0930\u0915\u094d\u0937\u093e \u092a\u094d\u0930\u094b\u092b\u093e\u0907\u0932 \u0915\u0947 \u0938\u093e\u0925 \u092c\u0921\u093c\u0947 \u0938\u094d\u0924\u0930 \u092a\u0930 \u0909\u092a\u0932\u092c\u094d\u0927 \u0915\u0930\u093e\u0928\u0947 \u092e\u0947\u0902 Immuneel \u0915\u0940 \u0915\u094d\u0937\u092e\u0924\u093e \u0915\u094b \u0926\u0930\u094d\u0936\u093e\u0924\u093e \u0939\u0948\u0964 \u0907\u0938 \u0921\u0947\u091f\u093e \u0915\u094b \u0935\u0948\u0936\u094d\u0935\u093f\u0915 \u092e\u0902\u091a\u094b\u0902 \u092a\u0930 22 \u0938\u0947 \u0905\u0927\u093f\u0915 \u092a\u094d\u0930\u0938\u094d\u0924\u0941\u0924\u093f\u092f\u094b\u0902 \u0914\u0930 \u092a\u094d\u0930\u0915\u093e\u0936\u0928\u094b\u0902 \u0915\u0947 \u0938\u093e\u0925-\u0938\u093e\u0925 Blood-Immunology & Cellular Therapy \u092e\u0947\u0902 \u092a\u094d\u0930\u0915\u093e\u0936\u093f\u0924 \u092e\u0942\u0932 \u0936\u094b\u0927 \u0932\u0947\u0916 \u0915\u093e \u0938\u092e\u0930\u094d\u0925\u0928 \u092a\u094d\u0930\u093e\u092a\u094d\u0924 \u0939\u0948\u0964<\/p>\n

Ms. Kiran Mazumdar-Shaw, \u092c\u094b\u0930\u094d\u0921 \u0921\u093e\u092f\u0930\u0947\u0915\u094d\u091f\u0930 \u090f\u0935\u0902 \u0915\u094b-\u092b\u093e\u0909\u0902\u0921\u0930, Immuneel Therapeutics \u0928\u0947 \u0915\u0939\u093e,<\/strong>
\u201cImmuneel \u0915\u0940 \u0938\u094d\u0925\u093e\u092a\u0928\u093e \u090f\u0915 \u0938\u094d\u092a\u0937\u094d\u091f \u0909\u0926\u094d\u0926\u0947\u0936\u094d\u092f \u0915\u0947 \u0938\u093e\u0925 \u0915\u0940 \u0917\u0908 \u0925\u0940 \u2014 \u092d\u093e\u0930\u0924 \u0915\u0947 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0909\u0928\u094d\u0928\u0924 \u0914\u0930 \u091c\u0940\u0935\u0928\u0930\u0915\u094d\u0937\u0915 \u0915\u0948\u0902\u0938\u0930 \u0909\u092a\u091a\u093e\u0930\u094b\u0902 \u0915\u094b \u0938\u0941\u0932\u092d \u0914\u0930 \u0915\u093f\u092b\u093e\u092f\u0924\u0940 \u092c\u0928\u093e\u0928\u093e\u0964 \u0939\u092e\u093e\u0930\u0940 \u092e\u0947\u0921-\u0907\u0928-\u0907\u0902\u0921\u093f\u092f\u093e CAR T \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u093e 100 \u0938\u0947 \u0905\u0927\u093f\u0915 \u092e\u0930\u0940\u091c\u094b\u0902 \u092e\u0947\u0902 \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u093f\u0915 \u0930\u094b\u0917\u092e\u0941\u0915\u094d\u0924\u093f \u092a\u094d\u0930\u0926\u093e\u0928 \u0915\u0930\u0928\u093e, \u0914\u0930 \u0915\u0908 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u093e \u0926\u094b \u0935\u0930\u094d\u0937\u094b\u0902 \u0938\u0947 \u0905\u0927\u093f\u0915 \u0938\u092e\u092f \u0924\u0915 remission \u092e\u0947\u0902 \u092c\u0928\u0947 \u0930\u0939\u0928\u093e, \u0939\u092e\u093e\u0930\u0947 \u0907\u0938 \u092e\u093f\u0936\u0928 \u0915\u0940 \u092e\u091c\u092c\u0942\u0924 \u092a\u0941\u0937\u094d\u091f\u093f \u0939\u0948\u0964 \u092f\u0947 \u0909\u0924\u094d\u0938\u093e\u0939\u091c\u0928\u0915 \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u093f\u0915 \u0935\u093e\u0938\u094d\u0924\u0935\u093f\u0915 \u092a\u0930\u093f\u0923\u093e\u092e \u0926\u0930\u094d\u0936\u093e\u0924\u0947 \u0939\u0948\u0902 \u0915\u093f \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0935\u093f\u0915\u0938\u093f\u0924 \u0928\u0935\u093e\u091a\u093e\u0930 \u0935\u0948\u0936\u094d\u0935\u093f\u0915 \u092e\u093e\u0928\u0915\u094b\u0902 \u092a\u0930 \u0916\u0930\u0947 \u0909\u0924\u0930 \u0938\u0915\u0924\u0947 \u0939\u0948\u0902 \u0914\u0930 \u0938\u093e\u0925 \u0939\u0940 \u0938\u094d\u0925\u093e\u0928\u0940\u092f \u0938\u094d\u0935\u093e\u0938\u094d\u0925\u094d\u092f \u091c\u0930\u0942\u0930\u0924\u094b\u0902 \u0915\u094b \u092c\u0921\u093c\u0947 \u0938\u094d\u0924\u0930 \u092a\u0930 \u092a\u0942\u0930\u093e \u0915\u0930 \u0938\u0915\u0924\u0947 \u0939\u0948\u0902\u0964 \u091c\u0948\u0938\u0947-\u091c\u0948\u0938\u0947 \u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u092a\u094d\u0930\u092e\u093e\u0923 \u0914\u0930 \u092e\u091c\u092c\u0942\u0924 \u0939\u094b\u0924\u0947 \u091c\u093e\u090f\u0902\u0917\u0947, Immuneel \u0905\u0917\u0932\u0940 \u092a\u0940\u0922\u093c\u0940 \u0915\u0940 \u092a\u0930\u093f\u0935\u0930\u094d\u0924\u0928\u0915\u093e\u0930\u0940 \u0915\u0948\u0902\u0938\u0930 \u0925\u0947\u0930\u0947\u092a\u0940 \u092e\u0947\u0902 \u092d\u093e\u0930\u0924 \u0915\u0940 \u0938\u094d\u0925\u093f\u0924\u093f \u0915\u094b \u0914\u0930 \u092e\u091c\u092c\u0942\u0924 \u0915\u0930\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u092a\u094d\u0930\u0924\u093f\u092c\u0926\u094d\u0927 \u0930\u0939\u0947\u0917\u093e\u0964\u201d<\/p>\n

Mr. Amit Mookim, \u092c\u094b\u0930\u094d\u0921 \u0921\u093e\u092f\u0930\u0947\u0915\u094d\u091f\u0930 \u090f\u0935\u0902 CEO, Immuneel Therapeutics \u0928\u0947 \u0915\u0939\u093e,<\/strong>
\u201c\u092f\u0939 \u0909\u092a\u0932\u092c\u094d\u0927\u093f \u0915\u0947\u0935\u0932 \u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u0938\u092b\u0932\u0924\u093e \u0928\u0939\u0940\u0902, \u092c\u0932\u094d\u0915\u093f \u0907\u0938 \u092c\u093e\u0924 \u0915\u093e \u0930\u0923\u0928\u0940\u0924\u093f\u0915 \u092a\u094d\u0930\u092e\u093e\u0923 \u092d\u0940 \u0939\u0948 \u0915\u093f \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0935\u093f\u0915\u0938\u093f\u0924 \u0935\u093f\u0936\u094d\u0935\u0938\u094d\u0924\u0930\u0940\u092f \u0935\u093f\u091c\u094d\u091e\u093e\u0928 \u092d\u093e\u0930\u0924 \u0914\u0930 \u0926\u0941\u0928\u093f\u092f\u093e \u0926\u094b\u0928\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0915\u094d\u092f\u093e \u0938\u0902\u092d\u0935 \u092c\u0928\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964 \u0915\u0908 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u093e \u0926\u094b \u0935\u0930\u094d\u0937\u094b\u0902 \u0938\u0947 \u0905\u0927\u093f\u0915 \u092a\u094d\u0930\u094b\u0917\u094d\u0930\u0947\u0936\u0928-\u092b\u094d\u0930\u0940 \u0938\u0930\u094d\u0935\u093e\u0907\u0935\u0932 \u0939\u093e\u0938\u093f\u0932 \u0915\u0930\u0928\u093e \u0926\u0930\u094d\u0936\u093e\u0924\u093e \u0939\u0948 \u0915\u093f \u092d\u093e\u0930\u0924 \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u093f\u0915 \u0914\u0930 \u0905\u0917\u0932\u0940 \u092a\u0940\u0922\u093c\u0940 \u0915\u0940 \u0925\u0947\u0930\u0947\u092a\u0940 \u0926\u0947\u0928\u0947 \u092e\u0947\u0902 \u0905\u0917\u094d\u0930\u0923\u0940 \u092d\u0942\u092e\u093f\u0915\u093e \u0928\u093f\u092d\u093e \u0938\u0915\u0924\u093e \u0939\u0948\u0964 Immuneel \u092e\u0947\u0902 \u0939\u092e\u093e\u0930\u093e \u092b\u094b\u0915\u0938 \u0909\u092a\u091a\u093e\u0930 \u0915\u0940 \u092a\u0939\u0941\u0902\u091a \u092c\u0922\u093c\u093e\u0928\u0947, \u092a\u094d\u0930\u092d\u093e\u0935 \u0915\u094b \u0917\u0939\u0930\u093e \u0915\u0930\u0928\u0947 \u0914\u0930 \u092d\u093e\u0930\u0924 \u0938\u0939\u093f\u0924 \u0926\u0941\u0928\u093f\u092f\u093e \u092d\u0930 \u0915\u0947 \u092e\u0930\u0940\u091c\u094b\u0902 \u0914\u0930 \u0909\u0928\u0915\u0947 \u092a\u0930\u093f\u0935\u093e\u0930\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u0915\u0948\u0902\u0938\u0930 \u0909\u092a\u091a\u093e\u0930 \u0915\u094b \u0928\u090f \u0930\u0942\u092a \u092e\u0947\u0902 \u092a\u0930\u093f\u092d\u093e\u0937\u093f\u0924 \u0915\u0930\u0928\u0947 \u092a\u0930 \u092c\u0928\u093e \u0930\u0939\u0947\u0917\u093e\u0964\u201d<\/p>\n

\u0935\u0948\u0936\u094d\u0935\u093f\u0915 \u0938\u094d\u0924\u0930 \u092a\u0930 CAR T \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u094b \u0915\u094d\u0930\u093e\u0902\u0924\u093f\u0915\u093e\u0930\u0940 \u092e\u093e\u0928\u093e \u091c\u093e\u0924\u093e \u0939\u0948, \u0932\u0947\u0915\u093f\u0928 \u0907\u0938\u0915\u0940 \u0932\u093e\u0917\u0924 \u0914\u0930 \u091c\u091f\u093f\u0932 \u092a\u094d\u0930\u0915\u094d\u0930\u093f\u092f\u093e \u0907\u0938\u0947 \u0938\u0940\u092e\u093f\u0924 \u092c\u0928\u093e\u0924\u0940 \u0930\u0939\u0940 \u0939\u0948\u0964 Immuneel \u0915\u093e \u092f\u0939 \u092a\u094d\u0930\u092f\u093e\u0938 \u092d\u093e\u0930\u0924\u0940\u092f \u092e\u0930\u0940\u091c\u094b\u0902, \u0935\u093f\u0936\u0947\u0937\u0915\u0930 \u0909\u0928 \u0932\u094b\u0917\u094b\u0902 \u0915\u0947 \u0932\u093f\u090f \u091c\u093f\u0928\u094d\u0939\u094b\u0902\u0928\u0947 \u0905\u0928\u094d\u092f \u0938\u092d\u0940 \u0909\u092a\u091a\u093e\u0930 \u0935\u093f\u0915\u0932\u094d\u092a \u0906\u091c\u092e\u093e \u0932\u093f\u090f \u0939\u0948\u0902, \u0907\u0928 \u0909\u0928\u094d\u0928\u0924 \u0909\u092a\u091a\u093e\u0930\u094b\u0902 \u0915\u094b \u0938\u0941\u0932\u092d \u092c\u0928\u093e\u0928\u0947 \u0915\u0940 \u0926\u093f\u0936\u093e \u092e\u0947\u0902 \u090f\u0915 \u092e\u0939\u0924\u094d\u0935\u092a\u0942\u0930\u094d\u0923 \u092e\u094b\u0921\u093c \u0938\u093e\u092c\u093f\u0924 \u0939\u094b \u0938\u0915\u0924\u093e \u0939\u0948\u0964<\/p>\n

\u092e\u0941\u0916\u094d\u092f \u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u0909\u092a\u0932\u092c\u094d\u0927\u093f\u092f\u093e\u0902:<\/h3>\n

\u2022 \u092d\u093e\u0930\u0924 \u0915\u0947 \u0938\u092c\u0938\u0947 \u0932\u0902\u092c\u0947 \u0938\u092e\u092f \u0924\u0915 \u091c\u0940\u0935\u093f\u0924 CAR T \u0925\u0947\u0930\u0947\u092a\u0940 \u0938\u0930\u094d\u0935\u093e\u0907\u0935\u0930:<\/strong> IMAGINE \u092b\u0947\u091c-2 \u091f\u094d\u0930\u093e\u092f\u0932 \u092e\u0947\u0902 \u0936\u093e\u092e\u093f\u0932 \u0938\u093e\u0924 \u092e\u0930\u0940\u091c\u094b\u0902 \u0928\u0947 \u0926\u094b \u0935\u0930\u094d\u0937\u094b\u0902 \u0938\u0947 \u0905\u0927\u093f\u0915 PFS \u0939\u093e\u0938\u093f\u0932 \u0915\u093f\u092f\u093e, \u091c\u094b \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0915\u093f\u0938\u0940 \u092d\u0940 CAR T \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0947 \u0932\u093f\u090f \u092a\u0939\u0932\u0940 \u0909\u092a\u0932\u092c\u094d\u0927\u093f \u0939\u0948 \u0914\u0930 \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u093f\u0915 \u0930\u094b\u0917\u092e\u0941\u0915\u094d\u0924\u093f \u0924\u0925\u093e \u092c\u0947\u0939\u0924\u0930 \u091c\u0940\u0935\u0928 \u092a\u094d\u0930\u0924\u094d\u092f\u093e\u0936\u093e \u0915\u0940 \u0938\u0902\u092d\u093e\u0935\u0928\u093e \u0915\u094b \u0926\u0930\u094d\u0936\u093e\u0924\u093e \u0939\u0948\u0964<\/p>\n

\u2022 \u092e\u091c\u092c\u0942\u0924 \u0914\u0930 \u0938\u094d\u0925\u093e\u092f\u0940 \u092a\u094d\u0930\u0924\u093f\u0915\u094d\u0930\u093f\u092f\u093e \u0926\u0930:<\/strong> IMN-003A (\u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u091f\u094d\u0930\u093e\u092f\u0932) \u092e\u0947\u0902 Day 90 \u092a\u0930 83% ORR, Day 365 \u092a\u0930 50% ORR \u0914\u0930 83% Complete Response Rate \u0926\u0930\u094d\u091c \u0915\u0940 \u0917\u0908, \u091c\u093f\u0938\u0928\u0947 relapsed\/refractory CD19+ B-NHL \u0915\u0947 \u0909\u092a\u091a\u093e\u0930 \u092e\u0947\u0902 \u0928\u090f \u092e\u093e\u0928\u0915 \u0938\u094d\u0925\u093e\u092a\u093f\u0924 \u0915\u093f\u090f\u0964<\/p>\n

\u2022 100 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u0940 \u0909\u092a\u0932\u092c\u094d\u0927\u093f:<\/strong> \u0935\u094d\u092f\u093e\u0935\u0938\u093e\u092f\u093f\u0915 \u0909\u092a\u092f\u094b\u0917 \u0915\u0947 \u092c\u093e\u0926 \u092f\u0939 \u0925\u0947\u0930\u0947\u092a\u0940 \u092d\u093e\u0930\u0924 \u0915\u0947 \u092a\u094d\u0930\u092e\u0941\u0916 \u0905\u0938\u094d\u092a\u0924\u093e\u0932\u094b\u0902 \u092e\u0947\u0902 100 \u0938\u0947 \u0905\u0927\u093f\u0915 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u094b \u0938\u092b\u0932\u0924\u093e\u092a\u0942\u0930\u094d\u0935\u0915 \u0926\u0940 \u091c\u093e \u091a\u0941\u0915\u0940 \u0939\u0948, \u091c\u093f\u0938\u092e\u0947\u0902 \u0932\u0917\u093e\u0924\u093e\u0930 \u0905\u091a\u094d\u091b\u0947 \u0915\u094d\u0932\u0940\u0928\u093f\u0915\u0932 \u092a\u0930\u093f\u0923\u093e\u092e, \u0905\u0928\u0941\u0915\u0942\u0932 \u0938\u0941\u0930\u0915\u094d\u0937\u093e \u092a\u094d\u0930\u094b\u092b\u093e\u0907\u0932 \u0914\u0930 \u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u0938\u094d\u0924\u0930 \u092a\u0930 \u091c\u091f\u093f\u0932 \u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0909\u092a\u0932\u092c\u094d\u0927 \u0915\u0930\u093e\u0928\u0947 \u0915\u0940 Immuneel \u0915\u0940 \u0915\u094d\u0937\u092e\u0924\u093e \u092a\u094d\u0930\u0926\u0930\u094d\u0936\u093f\u0924 \u0939\u0941\u0908\u0964<\/p>\n

\u2022 DBT-BIRAC \u0917\u094d\u0930\u093e\u0902\u091f \u0915\u093e \u0938\u092e\u0930\u094d\u0925\u0928:<\/strong> IMAGINE \u092b\u0947\u091c-2 \u091f\u094d\u0930\u093e\u092f\u0932 \u0915\u094b \u091c\u0948\u0935 \u092a\u094d\u0930\u094c\u0926\u094d\u092f\u094b\u0917\u093f\u0915\u0940 \u0935\u093f\u092d\u093e\u0917 \u0915\u0940 BIPP \u092f\u094b\u091c\u0928\u093e \u0915\u0947 \u0905\u0902\u0924\u0930\u094d\u0917\u0924 BIRAC (Biotechnology Industry Research Assistance Council) \u0915\u093e \u0938\u092e\u0930\u094d\u0925\u0928 \u092a\u094d\u0930\u093e\u092a\u094d\u0924 \u0925\u093e, \u091c\u094b \u0907\u0938\u0915\u0940 \u0935\u0948\u091c\u094d\u091e\u093e\u0928\u093f\u0915 \u0917\u0941\u0923\u0935\u0924\u094d\u0924\u093e \u0915\u0940 \u0930\u093e\u0937\u094d\u091f\u094d\u0930\u0940\u092f \u092e\u093e\u0928\u094d\u092f\u0924\u093e \u0915\u094b \u0926\u0930\u094d\u0936\u093e\u0924\u093e \u0939\u0948\u0964<\/p>\n

IMAGINE \u0905\u0927\u094d\u092f\u092f\u0928 \u0915\u0947 \u092c\u093e\u0930\u0947 \u092e\u0947\u0902<\/h3>\n

IMAGINE \u092b\u0947\u091c-2 \u091f\u094d\u0930\u093e\u092f\u0932 \u0935\u0930\u094d\u0937 2022 \u092e\u0947\u0902 \u0936\u0941\u0930\u0942 \u0915\u093f\u092f\u093e \u0917\u092f\u093e \u0925\u093e, \u091c\u093f\u0938\u0915\u093e \u0909\u0926\u094d\u0926\u0947\u0936\u094d\u092f relapsed \u0914\u0930 refractory CD19-positive B-cell malignancies \u092e\u0947\u0902 Varnimcabtagene autoleucel (IMN-003A) \u0915\u0940 \u0938\u0941\u0930\u0915\u094d\u0937\u093e \u0914\u0930 \u092a\u094d\u0930\u092d\u093e\u0935\u0936\u0940\u0932\u0924\u093e \u0915\u093e \u092e\u0942\u0932\u094d\u092f\u093e\u0902\u0915\u0928 \u0915\u0930\u0928\u093e \u0925\u093e\u0964<\/p>\n

\u091f\u094d\u0930\u093e\u092f\u0932 \u0935\u093f\u0935\u0930\u0923:<\/h3>\n

\u2022 Clinical Trial Registry Number:<\/strong> CTRI\/2022\/03\/041162<\/p>\n

\u2022 Study Sites (Original Trial):<\/strong>
o Narayana Health- Mazumdar Shaw Medical Center, Bangalore
o Apollo Cancer Center, Chennai
o PGIMER, Chandigarh<\/p>\n

\u2022 Extended Trial Site:<\/strong>
o CMC Vellore
o Rajiv Gandhi Cancer Institute, New Delhi<\/p>\n

\u0905\u0927\u094d\u092f\u092f\u0928 \u092e\u0947\u0902 \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0940 \u0905\u0928\u0941\u0915\u0942\u0932 \u0938\u0941\u0930\u0915\u094d\u0937\u093e \u092a\u094d\u0930\u094b\u092b\u093e\u0907\u0932 \u0915\u0940 \u092a\u0941\u0937\u094d\u091f\u093f \u0939\u0941\u0908, \u091c\u093f\u0938\u092e\u0947\u0902 \u0917\u0902\u092d\u0940\u0930 \u0928\u094d\u092f\u0942\u0930\u094b\u091f\u0949\u0915\u094d\u0938\u093f\u0938\u093f\u091f\u0940 \u0928\u0939\u0940\u0902 \u0926\u0947\u0916\u0940 \u0917\u0908 \u0914\u0930 \u092e\u0930\u0940\u091c\u094b\u0902 \u0915\u0947 \u091c\u0940\u0935\u0928 \u0915\u0940 \u0917\u0941\u0923\u0935\u0924\u094d\u0924\u093e \u092e\u0947\u0902 \u092e\u0939\u0924\u094d\u0935\u092a\u0942\u0930\u094d\u0923 \u0938\u0941\u0927\u093e\u0930 \u0915\u0947 \u0938\u093e\u0925 \u0926\u0940\u0930\u094d\u0918\u0915\u093e\u0932\u093f\u0915 \u092a\u094d\u0930\u0924\u093f\u0915\u094d\u0930\u093f\u092f\u093e \u0926\u0930\u094d\u091c \u0915\u0940 \u0917\u0908\u0964<\/p>\n

Immuneel Therapeutics \u0915\u0947 \u092c\u093e\u0930\u0947 \u092e\u0947\u0902<\/h3>\n

\u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0938\u0947\u0932 \u090f\u0935\u0902 \u091c\u0940\u0928 \u0925\u0947\u0930\u0947\u092a\u0940 \u0914\u0930 \u092a\u0930\u094d\u0938\u0928\u0932\u093e\u0907\u091c\u094d\u0921 \u0907\u092e\u094d\u092f\u0942\u0928\u094b\u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0947 \u0915\u094d\u0937\u0947\u0924\u094d\u0930 \u092e\u0947\u0902 \u092a\u0930\u093f\u0935\u0930\u094d\u0924\u0928 \u0932\u093e\u0928\u0947 \u0935\u093e\u0932\u0940 \u090f\u0915 \u0905\u0917\u094d\u0930\u0923\u0940 \u0938\u094d\u091f\u093e\u0930\u094d\u091f-\u0905\u092a \u0915\u0902\u092a\u0928\u0940 \u0939\u0948\u0964 \u092c\u0947\u0902\u0917\u0932\u0941\u0930\u0941 \u092e\u0941\u0916\u094d\u092f\u093e\u0932\u092f \u0935\u093e\u0932\u0940 \u092f\u0939 \u0930\u093f\u0938\u0930\u094d\u091a-\u0906\u0927\u093e\u0930\u093f\u0924, \u092a\u0942\u0930\u094d\u0923\u0924\u0903 \u090f\u0915\u0940\u0915\u0943\u0924 \u0938\u0947\u0932 \u090f\u0935\u0902 \u091c\u0940\u0928 \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u0902\u092a\u0928\u0940 \u092d\u093e\u0930\u0924 \u092e\u0947\u0902 \u0915\u093f\u092b\u093e\u092f\u0924\u0940 \u0926\u0930\u094b\u0902 \u092a\u0930 \u0905\u0924\u094d\u092f\u093e\u0927\u0941\u0928\u093f\u0915 \u0915\u0948\u0902\u0938\u0930 \u0909\u092a\u091a\u093e\u0930 \u0909\u092a\u0932\u092c\u094d\u0927 \u0915\u0930\u093e\u0928\u0947 \u0914\u0930 \u0905\u0917\u0932\u0940 \u092a\u0940\u0922\u093c\u0940 \u0915\u0940 \u0938\u0947\u0932 \u0925\u0947\u0930\u0947\u092a\u0940 \u0915\u093e \u092a\u094b\u0930\u094d\u091f\u092b\u094b\u0932\u093f\u092f\u094b \u0935\u093f\u0915\u0938\u093f\u0924 \u0915\u0930\u0928\u0947 \u0915\u0947 \u0932\u093f\u090f \u092a\u094d\u0930\u0924\u093f\u092c\u0926\u094d\u0927 \u0939\u0948\u0964 \u0905\u0927\u093f\u0915 \u091c\u093e\u0928\u0915\u093e\u0930\u0940 \u0915\u0947 \u0932\u093f\u090f Immuneel Therapeutics \u0926\u0947\u0916\u0947\u0902\u0964<\/p>\n

\n
\n
\n
\n
\n
\n
\n
\n
\n

\u0905\u0938\u094d\u0935\u0940\u0915\u0930\u0923:<\/strong> \u092f\u0939 \u092a\u094d\u0930\u0947\u0938 \u0935\u093f\u091c\u094d\u091e\u092a\u094d\u0924\u093f \u0915\u0947\u0935\u0932 \u0938\u093e\u092e\u093e\u0928\u094d\u092f \u091c\u093e\u0928\u0915\u093e\u0930\u0940 \u092a\u094d\u0930\u0926\u093e\u0928 \u0915\u0930\u0928\u0947 \u0915\u0947 \u0909\u0926\u094d\u0926\u0947\u0936\u094d\u092f \u0938\u0947 \u091c\u093e\u0930\u0940 \u0915\u0940 \u0917\u0908 \u0939\u0948\u0964 \u0907\u0938\u0947 \u091a\u093f\u0915\u093f\u0924\u094d\u0938\u0915\u0940\u092f \u0938\u0932\u093e\u0939 \u0915\u093e \u0935\u093f\u0915\u0932\u094d\u092a \u0928 \u092e\u093e\u0928\u093e \u091c\u093e\u090f\u0964 \u0915\u093f\u0938\u0940 \u092d\u0940 \u0938\u094d\u0935\u093e\u0938\u094d\u0925\u094d\u092f \u0938\u0902\u092c\u0902\u0927\u0940 \u0928\u093f\u0930\u094d\u0923\u092f \u0932\u0947\u0928\u0947 \u0938\u0947 \u092a\u0939\u0932\u0947 \u092f\u094b\u0917\u094d\u092f \u0921\u0949\u0915\u094d\u091f\u0930 \u0938\u0947 \u092a\u0930\u093e\u092e\u0930\u094d\u0936 \u0905\u0935\u0936\u094d\u092f \u0915\u0930\u0947\u0902\u0964<\/em><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

\u092c\u0947\u0902\u0917\u0932\u0941\u0930\u0941 (\u0915\u0930\u094d\u0928\u093e\u091f\u0915) [\u092d\u093e\u0930\u0924], 21 \u092e\u0908: \u092d\u093e\u0930\u0924\u0940\u092f \u0911\u0928\u094d\u0915\u094b\u0932\u0949\u091c\u0940 \u0926\u0947\u0916\u092d\u093e\u0932 \u092e\u0947\u0902 \u090f\u0915 \u092e\u0939\u0924\u094d\u0935\u092a\u0942\u0930\u094d\u0923 \u0909\u092a\u0932\u092c\u094d\u0927\u093f \u0915\u0947 \u0930\u0942\u092a \u092e\u0947\u0902,…<\/p>\n","protected":false},"author":4,"featured_media":3468,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[22],"tags":[],"class_list":["post-3466","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health"],"_links":{"self":[{"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/posts\/3466","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/comments?post=3466"}],"version-history":[{"count":1,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/posts\/3466\/revisions"}],"predecessor-version":[{"id":3467,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/posts\/3466\/revisions\/3467"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/media\/3468"}],"wp:attachment":[{"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/media?parent=3466"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/categories?post=3466"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kanpurlive.in\/hn\/wp-json\/wp\/v2\/tags?post=3466"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}